Analysts expect Neurogene Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.93 M | 21.90 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.01 M | 18.07 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.47 M | 19.99 M |
Analysts expect Neurogene Inc. to report earnings per share of -1.25 for Q3 26, against a range of -1.31 to -1.19. The most recent reported quarter, Q2 26, came in at -1.53, a 12.5% miss against the -1.36 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.19 | -1.00 | -1.08 | -1.05 | -0.99 | -1.12 | -1.39 | -1.53 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.09 | -1.15 | -1.02 | -1.09 | -1.15 | -1.09 | -1.28 | -1.23 | -1.19 | -1.15 | -1.22 | -1.25 | -1.20 | -1.28 | -1.08 | -0.97 | ||||||||||
| Low Estimate | -1.19 | -1.25 | -1.16 | -1.17 | -1.25 | -1.31 | -1.38 | -1.49 | -1.31 | -1.37 | -1.46 | -1.47 | -1.42 | -1.40 | -1.30 | -1.13 | ||||||||||
| Consensus Estimate | -1.14 | -1.20 | -1.09 | -1.13 | -1.20 | -1.20 | -1.33 | -1.36 | -1.25 | -1.26 | -1.34 | -1.36 | -1.31 | -1.34 | -1.19 | -1.05 |
Pull Wall Street consensus for Neurogene Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NGNE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NGNE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NGNE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();